Effect of Pelvic Beam Radiation Therapy on Lower Urinary Tract Function of Pediatric Patients

Authors:

Abstract
Background : Pediatric patients with pelvic solid tumors often receive multi-modal treatment but the long-term effects of this treatment on lower urinary tract (LUT) function are not well-described. This prospective cohort study (NCT05818462) investigates the effect of EBRT on LUT function by comparing patient-reported outcome measures, non-invasive urodynamic studies, and post-void residuals (PVRs) amongst childhood cancer survivors (CCS). Methods : All subjects were CCS >1 year off-therapy for a pediatric solid tumor. Subjects were divided into two cohorts: a study cohort of patients who received pelvic EBRT and a control cohort who received only chemotherapy. Research subjects completed the Dysfunctional Voiding Scoring system (DVSS) survey, uroflow testing, and PVR bladder scan. Results : Thirty-two patients enrolled. Sixteen patients received pelvic EBRT. There were an equal number of patients exposed to alkylators (69%) in each cohort. The study cohort was more likely to have abnormal uroflow patterns (81% vs 56%, p=0.12). The flow pattern distribution differed between groups (p=0.03); the study cohort was more likely to have a “plateau” shaped curve (44% vs 6%) and abnormal PVR (OR 9.0, p=0.002). Exploratory conditional likelihood ratio models yielded potential associations between pelvic EBRT and LUTD, as well as a potential dose-response. There was no difference in DVSS scores between cohorts. Conclusion : EBRT appears to affect LUT function in CCS who received pelvic EBRT. DVSS does not appear useful as a screening tool in this population. Further study is needed to better appreciate the impact of EBRT on LUT function and develop more accurate screening tools.